Telomir Pharmaceuticals Inc

Research Telomir Pharmaceuticals Inc (TELO) on Bullrun: market cap USD 85.97M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerTELO
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 85.97M
• Financial periodFY2025
• Net income-USD 10.41M

Valuation Snapshot

latest market cap is USD 85.97M.

About Telomir Pharmaceuticals Inc

Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against age-related conditions, including Wilson's disease, Type 2 diabetes, age-related macular degeneration (AMD), oncology, and epigenetic regulation, as well as Alzheimer's disease and Progeria.

Frequently asked questions

What is Telomir Pharmaceuticals Inc's market cap?

Telomir Pharmaceuticals Inc's market capitalization is USD 85.97M.

What does Telomir Pharmaceuticals Inc do?

Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases.